A Clinical Trial to Evaluate the Immunogenicity and Safety of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) in Adults Aged 18 to 55 Years

Clinical trial NCT06131554 · COMPLETED

Trial details

NCT number: NCT06131554
Sponsor: CanSino Biologics Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Meningococcal Meningitis

Start date: 2024-03-20
Primary completion: 2024-07-12
Enrollment: 1480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.